FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumors ...Middle East

Medscape - News
FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumors
Vimseltinib is the second CSF1 receptor blocker to enter the US market for tenosynovial giant cell tumors. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumors )

Also on site :